CCR Podcast 1 - Paul Young on ICU-ROX
ICU-ROX is a phase 2b, parallel group, multi-centre, randomised, single blinded clinical trial comparing liberal with conservative oxygen therapy in mechanically ventilated adults in the Intensive Care Unit. Its chief investigator is Dr Paul Young, from Wellington, New Zealand, who talks with Rob Mac Sweeney about both ICU-ROX and the REACTOR trial.
- ICU-ROX trial registration
- Wellington ICU
- ANZICS Clinical Trials Group
- Paul Young presenting at the Critical Care Reviews Meeting 2016
- Paul Young on Twitter (please retweet his June 16th NEJM tweet)